A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

G. Borthakur, H. Dombret, P. Schafhausen, T. H. Brummendorf, N. Boissel, E. Jabbour, M. Mariani, L. Capolongo, P. Carpinelli, C. Davite, H. Kantarjian, J. E. Cortes

Open source

DOI: 10.3324/haematol.2014.115279
Published: 2015-04-17
Container: Haematologica
Publisher: Ferrata Storti Foundation (Haematologica)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2014.115279,
  title = {A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy},
  author = {G. Borthakur and H. Dombret and P. Schafhausen and T. H. Brummendorf and N. Boissel and E. Jabbour and M. Mariani and L. Capolongo and P. Carpinelli and C. Davite and H. Kantarjian and J. E. Cortes},
  year = {2015},
  journal = {Haematologica},
  doi = {10.3324/haematol.2014.115279},
  url = {https://doi.org/10.3324/haematol.2014.115279}
}

RIS

TY  - JOUR
TI  - A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy
AU  - G. Borthakur
AU  - H. Dombret
AU  - P. Schafhausen
AU  - T. H. Brummendorf
AU  - N. Boissel
AU  - E. Jabbour
AU  - M. Mariani
AU  - L. Capolongo
AU  - P. Carpinelli
AU  - C. Davite
AU  - H. Kantarjian
AU  - J. E. Cortes
PY  - 2015
JO  - Haematologica
DO  - 10.3324/haematol.2014.115279
UR  - https://doi.org/10.3324/haematol.2014.115279
ER  -

APA

Borthakur, G., Dombret, H., Schafhausen, P., Brummendorf, T. H., Boissel, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., Kantarjian, H., & Cortes, J. E. (2015). A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. Haematologica. https://doi.org/10.3324/haematol.2014.115279

Source records

crossref · retrieved 2026-09-27T13:11:13.900Z